EIKN insider transactions
Eikon Therapeutics Inc. (EIKN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
EIKN insiders
Everyone who has filed a Form 4 or 5 at Eikon Therapeutics Inc., latest first. Follow anyone to get their next filing.
- Column Group IV GP, LP10% owner+$39.2M
- Michael A KlobucharChief Operating Officer
- Robert Luther HuffinesDirector
- Kenneth C FrazierDirector+$2M
- Roger M PerlmutterOfficer, Director
- Benjamin Bruno ThornerOfficer
- Roy D. BaynesChief Medical Officer
- Alfred Lloyd Bowie Jr.Chief Financial Officer
- Foresite Capital Management IV, LLC10% owner+$1,000K
- Josh WolfeDirector, 10% owner+$5M
- Lux Venture Partners V, LLC10% owner+$5M
Recent Form 3, 4, and 5 filings for EIKN
- Large owner Column Group Iv Gp, Lp bought $1,031,045 worth of shares (89,200 units at $11.56) (SEC Form 4)4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 3 filed by new insider Francisco Ma. Fatima3 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Klobuchar Michael A4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 4 filed by Director Huffines Robert Luther4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 4 filed by Director Frazier Kenneth C4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 4 filed by Officer Perlmutter Roger M4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 4 filed by Officer Thorner Benjamin Bruno4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Baynes Roy D.4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Bowie Alfred Lloyd Jr.4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- Officer Perlmutter Roger M converted options into 284,857 shares (SEC Form 4)4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- Large owner Column Group Iv Gp, Lp converted options into 3,595,340 shares and bought $38,119,680 worth of shares (2,117,760 units at $18.00) (SEC Form 4)4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- Large owner Foresite Capital Management Iv, Llc converted options into 4,041,687 shares and bought $999,990 worth of shares (55,555 units at $18.00) (SEC Form 4)4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- Director Frazier Kenneth C bought $1,999,998 worth of shares (111,111 units at $18.00) (SEC Form 4)4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- Director Wolfe Josh bought $4,999,968 worth of shares (277,776 units at $18.00) and converted options into 5,695,010 shares (SEC Form 4)4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
- Large owner Lux Venture Partners V, Llc bought $4,999,968 worth of shares (277,776 units at $18.00) and converted options into 5,695,010 shares (SEC Form 4)4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)